These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Extended-Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction. Nanayakkara S; Byrne M; Mak V; Carter K; Dean E; Kaye DM J Am Heart Assoc; 2020 Jul; 9(13):e015026. PubMed ID: 32552264 [TBL] [Abstract][Full Text] [Related]
3. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study. López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113 [TBL] [Abstract][Full Text] [Related]
4. Extended release oral milrinone as an adjunct to heart failure therapy. Nanayakkara S; Bergin P; Mak V; Crannitch K; Kaye DM Intern Med J; 2017 Aug; 47(8):973-974. PubMed ID: 28782207 [No Abstract] [Full Text] [Related]
5. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. Cesario D; Clark J; Maisel A Am Heart J; 1998 Jan; 135(1):121-9. PubMed ID: 9453531 [TBL] [Abstract][Full Text] [Related]
6. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience. Malotte K; Saguros A; Groninger H J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210 [TBL] [Abstract][Full Text] [Related]
7. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation. Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282 [TBL] [Abstract][Full Text] [Related]
8. Milrinone in advanced heart failure: dose and therapeutic monitor outside intensive care unit. Charisopoulou D; Leaver N; Banner NR Angiology; 2014 Apr; 65(4):343-9. PubMed ID: 23620310 [TBL] [Abstract][Full Text] [Related]
9. Sustained release of milrinone delivered via microparticles in a rodent model of myocardial infarction. Al Kindi H; Paul A; You Z; Nepotchatykh O; Schwertani A; Prakash S; Shum-Tim D J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2316-23. PubMed ID: 25175952 [TBL] [Abstract][Full Text] [Related]
10. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes. López-Candales AL; Carron C; Schwartz J Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852 [TBL] [Abstract][Full Text] [Related]
11. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355 [TBL] [Abstract][Full Text] [Related]
12. Predictors of clinical outcome in advanced heart failure patients on continuous intravenous milrinone therapy. Bhat G ASAIO J; 2006; 52(6):677-81. PubMed ID: 17117058 [TBL] [Abstract][Full Text] [Related]
13. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. Felker GM; Benza RL; Chandler AB; Leimberger JD; Cuffe MS; Califf RM; Gheorghiade M; O'Connor CM; J Am Coll Cardiol; 2003 Mar; 41(6):997-1003. PubMed ID: 12651048 [TBL] [Abstract][Full Text] [Related]
14. Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. Mehra MR; Ventura HO; Kapoor C; Stapleton DD; Zimmerman D; Smart FW Am J Cardiol; 1997 Jul; 80(1):61-4. PubMed ID: 9205021 [TBL] [Abstract][Full Text] [Related]
15. Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure. Jennings DL; Thompson ML Ann Pharmacother; 2009 Nov; 43(11):1872-6. PubMed ID: 19789358 [TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure. Cusick DA; Pfeifer PB; Quigg RJ Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]